Administration in HIV-Infected Patients Are Directly Related to the Baseline Level of Immune Activation

Irini Sereti(National Institutes of Health), H. Clifford Lane(National Institute of Allergy and Infectious Diseases), Joseph A. Kovacs(National Institutes of Health Clinical Center), Hiromi Imamichi(National Institutes of Health), Rebecca DerSimonian(National Institutes of Health), Jorge A. Tavel, Julia A. Metcalf(National Institutes of Health), Richard T. Davey(National Institutes of Health), Meena S. Ramchandani(Public Health – Seattle & King County), Sarah W. Read(National Institutes of Health), Vinay K. Aggarwal(National Institutes of Health), Ven Natarajan(National Cancer Institute), Peter Sklar(Merck & Co., Inc., Rahway, NJ, USA (United States))
Unknown
January 1, 2007
Cited by 0

Related Papers

Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
|Journal of Clinical Oncology|2014|714
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
|Nature|2014|437
Integrated Portable Genetic Analysis Microsystem for Pathogen/Infectious Disease Detection
|Analytical Chemistry|2004|283